Standout Papers

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis 2011 2026 2016 2021 775
  1. Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis (2011)
    Luca Richeldi, Ulrich Costabel et al. New England Journal of Medicine

Immediate Impact

33 by Nobel laureates 38 from Science/Nature 85 standout
Sub-graph 1 of 21

Citing Papers

Interstitial lung diseases
2022 Standout
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis
2022 Standout
67 intermediate papers

Works of Kevin Flaherty being referenced

Idiopathic non‐specific interstitial pneumonia
2015
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
2011 Standout
and 13 more

Author Peers

Author Last Decade Papers Cites
Kevin Flaherty 3856 1453 1366 68 5.9k
Edward Rubenstein 2279 202 839 110 7.3k
Robert Pascal 714 913 204 147 4.7k
Tohru Takahashi 1598 172 606 425 6.5k
P. Dufour 464 2275 130 207 5.0k
Takashi Okamura 349 768 198 293 6.0k
Alton B. Farris 895 65 336 176 6.0k
Naoki Iwamoto 240 583 327 229 4.7k
James W. Ryan 731 180 742 197 5.3k
R. R. Anderson 401 1802 351 114 6.0k
Georg F. Weber 389 640 230 130 8.4k

All Works

Loading papers...

Rankless by CCL
2026